The Department of Health Policy and Management (HPM) has a rich history of educating individuals for careers in health policy and management since its inception in 1950. Our strengths include the areas of health system governance and management, long-term care, Medicare and Medicaid policy, pharmaceutical policy, mathematical modeling and simulation, and health economics.

We prepare students in our MPH (and JD/MPH) programs to develop and advocate for public policies, create policy regulation, and work in governmental and public health sectors. Our MHA (and MHA-MBA) are prepared to fill key leadership positions in health care systems, hospitals, health insurance firms, consulting firms, physician groups, long-term care, and many other health-related organizations. As successful health care system executives these graduates provide leadership and are skilled in the management, financing and delivery of services, technological innovations, health policy and regulatory requirements, and public health and disease prevention strategies.

Students in our research-focused MS and PHD programs develop the rigorous analytical and quantitative skills needed for careers in top academic settings, government, and industry.

Maximize Find a research program for your interests

Maximize Pursue a career in health policy and management

Maximize HPM Academic Programs

 

Donohue finds more Americans are receiving addiction treatment, but gaps persist

PITTWIRE - Substantially more...
Donohue finds more Americans are receiving addiction treatment, but gaps persist

PITTWIRE - Substantially more people in the U.S. with opiiod use disorder are receiving evidence-based treatment for the disease, but there are still considerable gaps in care along racial lines, according to the largest analysis to date of opioid use disorder among Medicaid recipients. The results... (07/23/2021)

Donohue study says Opioid Use Disorder Treatment Rises in Medicaid Recipients

MEDPAGE TODAY - The proportio...
Donohue study says Opioid Use Disorder Treatment Rises in Medicaid Recipients

MEDPAGE TODAY - The proportion of people with opioid use disorder who received buprenorphine (Buprenex), methadone, or naltrexone (Revia) increased from 47.8% to 57.1% in an exploratory serial cross-sectional study by HPM Chair Julie Donohue and colleagues.  (07/23/2021)

Gellad on Whether America's Drug-Approval System is Unsustainable

THE ATLANTIC - "The FDA speci...
Gellad on Whether America's Drug-Approval System is Unsustainable

THE ATLANTIC - "The FDA specifically does not really worry about those larger societal issues and doesn't really worry about cost," HPM's Wallid Gellad said. Instead, the agency is judged by how many drugs it can approve.  (07/23/2021)

Drake: Marijuana legalization linked to temporary decrease in opioid-related emergency visits

MEDICAL XPRESS - States that ...
Drake: Marijuana legalization linked to temporary decrease in opioid-related emergency visits

MEDICAL XPRESS - States that legalize recreational marijuana experience a short-term decline in opioid-related emergency department visits, particularly among 25- to 44-year olds and men, according to analysis led by HPM's Coleman Drake.  (07/23/2021)

Drake: How To Improve Consumer Plan Selection in ACA Marketplaces

HEALTH AFFAIRS  - There is cu...
Drake: How To Improve Consumer Plan Selection in ACA Marketplaces

HEALTH AFFAIRS  - There is currently an opportunity for the Centers for Medicare and Medicaid Services to help consumers enroll in better Marketplace coverage in 2022. By adjusting how returning Marketplace enrollees are automatically re-enrolled in coverage, CMS can nudge more enrollees into plans... (07/23/2021)